Handheld Ultrasound Devices Market | USD 553.02 Million by 2034
The handheld ultrasound devices market size was exhibited at USD 316.18 million in 2024 and is projected to hit around USD 553.02 million by 2034, growing at a CAGR of 5.75% during the forecast period 2025 to 2034.
The U.S. handheld ultrasound devices market size is evaluated at USD 71.1 million in 2024 and is projected to be worth around USD 124.4 million by 2034, growing at a CAGR of 5.21% from 2025 to 2034.
North America dominated the global market in 2024 with the largest share of around 29.0% by revenue. Owing to factors such as the increased use of ultrasound technology in primary care settings, easy accessibility, and high healthcare spending in countries with effective reimbursement policies. The growing incidence of chronic disorders in this region, including breast cancer, cardiovascular disorders, and neurological diseases, has created a high demand for imaging analysis. The region is expected to maintain its dominance over the forecast period. Technological innovations and the growing incidence of chronic conditions are anticipated to propel the handheld ultrasound device market in the region.
U.S. Handheld Ultrasound Devices Market Trends
The U.S. handheld ultrasound devices market is expected to grow over the forecast period driven by aging demographic trends, advancing technologies, changing patient care strategies, and evolving epidemiological patterns. As the population ages, the demand for portable and affordable diagnostic solutions is increasing, making handheld ultrasound devices a popular choice for healthcare professionals. In addition, the emergence of new technologies is enhancing the capabilities of these devices, making them a valuable addition to healthcare practices.
Europe Handheld Ultrasound Devices Market Trends
Rising demand for healthcare devices and growing prevalence of chronic disorders & pain-associated disorders in Europe are some of the major factors anticipated to propel handheld ultrasound devices market in Europe.
The UK handheld ultrasound devices market is expected to grow at a fastest rate over the forecast period owing to technological advancements, growing awareness regrading diagnostic imaging methods and the increasing prevalence of chronic disorders.
The France handheld ultrasound devices market is expected to grow over the forecast period as it has a strong healthcare infrastructure, which meets the healthcare needs of its citizens. This favors the use of advanced handheld ultrasound devices.
The Germany handheld ultrasound devices market is expected to grow over the forecast period due to the need for advanced and efficient diagnostic devices, the presence of a sophisticated healthcare system, and a highly qualified workforce. These factors are anticipated to increase the adoption of handheld ultrasound devices in Germany and drive market growth.
Asia Pacific Handheld Ultrasound Devices Market Trends
Asia Pacific handheld ultrasound devices market in Asia Pacific is anticipated to exhibit significant growth over the forecast period. This can be attributed to rapid growth of the population and increased R&D activity in this region. In addition, there is a high need for traditional and as well as advanced devices in Asia Pacific.
Handheld ultrasound devices market in China is expected to grow owing to the changes in demographics & disease patterns and the growth of the private healthcare sector.
Japan handheld ultrasound devices market is projected to experience the fastest growth, over the forecast period. This growth can be attributed to the country's strong focus on technological innovation and Research & Development (R&D), providing an ideal environment for the advancement of handheld ultrasound devices technology.
Latin America Handheld Ultrasound Devices Market Trends
The handheld ultrasound devices market in Latin America is anticipated to undergo moderate growth throughout the forecast period. This growth is driven by several factors, including the presence of rapidly developing economies (such as Brazil & Mexico).
MEA Handheld Ultrasound Devices Market Trends
The Middle East & Africa handheld ultrasound devices market is anticipated to experience moderate growth during the forecast period owing to the increased focus of countries like Saudi Arabia and Kuwait towards enhancing their healthcare sectors.
Saudi Arabia handheld ultrasound devices market is expected to grow at a significant rate owing to technological advancements and growing awareness regarding early diagnosis by imaging devices.
Handheld ultrasound devices market in Kuwait is expected to grow owing to the favorable medical insurance and rapid adoption of advanced imaging in the country.
| Report Coverage | Details |
| Market Size in 2025 | USD 334.36 Million |
| Market Size by 2034 | USD 553.02 Million |
| Growth Rate From 2025 to 2034 | CAGR of 5.75% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Technology, Application, End use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | GE HealthCare; Koninklijke Philips N.V.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; BenQ Medical Technology; CHISON Medical Technologies Co., Ltd.; Dawei Medical (Jiangsu) Corp., Ltd.; Viatom Technology Co., Ltd.; Telemed Medical Systems S.r.l.; Butterfly Network, Inc; Pulsenmore Ltd.; Leltek Inc, |
The 3D/4D ultrasound segment dominated the market with the highest revenue share of around 46.69% in 2024, and it is expected to grow at the highest compound annual growth rate (CAGR) of 6.16% from 2025 to 2034. 3D and 4D handheld ultrasound devices are widely used in cardiovascular monitoring to determine blood flow through arteries and veins. In addition, 3D/4D units are increasingly being used in breast imaging for breast cancer screening, as they provide better visualization of the coronal plane. Therefore, the growing prevalence of cancer is likely to boost the demand for 3D/4D handheld ultrasound devices. For instance, according to the International Agency for Research on Cancer in 2022 about 2,380, 189 cancer cases were observed. Also, 3D/4D ultrasound imaging is gaining acceptance in obstetrics/gynecology. These factors are expected to propel the handheld ultrasound device market during the forecast period.
The 2D ultrasound segment is also expected to grow at a significant rate from 2025 to 2034. The demand for 2D handheld ultrasound is primarily attributed to its easy user interface and affordable cost. 2D handheld ultrasound devices are more commonly used in obstetrics, cardiology, and women's health. 2D handheld ultrasound devices create black-and-white images that show the baby's skeletal structure and make internal organs visible. The frequent launch of new products that offer improved imaging, workflow, and ergonomic capabilities is anticipated to drive this segment. For instance, in August 2023, Siemens Healthineers introduced a dedicated cardiovascular ultrasound system with 2D HeartAI and 4D HeartAI robust artificial intelligence (AI) features.
The hospital segment held the largest revenue share of 43.0% in 2024. This growth can be attributed to the higher number and type of ultrasound studies performed in hospitals than in any other healthcare setting. On average, a hospital may require at least three ultrasound scanners, one dedicated to general radiology, one for obstetrics and gynecology, and one for cardiac scanning. Also, the increasing number of private hospitals to address the growing burden of chronic illness is expected to drive the demand for handheld ultrasound devices. On the other hand, handheld ultrasound is becoming one of the key diagnostic tools during emergency visits and bedside monitoring.
In October 2020, GE Healthcare partnered with St. Luke’s University Health Network-a nonprofit, fully integrated, regional, nationally recognized network providing services at 12 hospitals-to install 76 ultrasound systems. The primary clinics segment is expected to grow at the highest CAGR of 6.30% from 2025 to 2034. In primary care, POCUS has been shown to increase the physician’s ability to detect heart failure accurately, improving management. It was also more sensitive to identifying pneumonia than the combined chest X-ray and clinical examination. POCUS is the benchmark of care for procedural guidance and enables the clinician to quickly recognize a variety of life-threatening entities and guide the management of hemodynamically unstable patients.
Based on application, the musculoskeletal segment dominated the market with a revenue share of 21.53% in 2024. The identification, highlighting, and measurement of tendon structures in the foot, ankle, and knee are done automatically by an Artificial Intelligence (AI) used for musculoskeletal (MSK) imaging that operates with handheld point-of-care ultrasound devices. Technological advancements in products and the launch of novel products by industry key players are boosting the industry's growth. GE HealthCare's Vscan Air offers simple patient imaging at the point of care. It assesses diseases, such as joint effusion, tendon and ligament injuries, bone fractures, and inflammation (tendonitis) across the MSK system of the body. MSK ultrasound is utilized with Vscan Air to support injury identification and guided interventions in clinics, radiology, sports medicine, outpatient settings, or everywhere necessary.
The trauma segment is expected to grow at the highest CAGR of 6.21% from 2025 to 2034. Trauma physicians use point-of-care ultrasonography (POCUS) as a helpful imaging method. Rapidly identifying injuries that threaten life and necessitate action is made possible by ultrasonography. A few ultrasound applications in the trauma department include obstetrics, soft tissue/MSK, abdominal ultrasonography of the right upper quadrant and appendix, and testicular and ocular ultrasonography. When traditional diagnostic techniques either take too long or put a person in more danger, ultrasonography is utilized to quickly diagnose a small number of injuries or pathologic diseases in the emergency medicine department.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the handheld ultrasound devices market
By Technology
By Application
By End-use
By Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Handheld Ultrasound Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing adoption of handheld ultrasound devices for diagnosis and treatment
3.2.1.2. Rising demand for minimally invasive surgical procedures
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. Lack of skilled professionals
3.2.2.2. Limitations of the handheld ultrasound devices
3.3. Handheld Ultrasound Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Handheld Ultrasound Devices Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2024 & 2034
4.2. Segment Dashboard
4.3. Global Handheld Ultrasound Devices Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
4.4.1. 2D Ultrasound
4.4.1.1. 2D ultrasound market estimates and forecasts 2021 to 2034 (USD Million)
4.4.2. 3D/4D Ultrasound
4.4.2.1. 3D/4D ultrasound market estimates and forecasts 2021 to 2034 (USD Million)
4.4.3. Doppler Ultrasound
4.4.3.1. Doppler ultrasound market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 5. Handheld Ultrasound Devices Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2024 & 2034
5.2. Segment Dashboard
5.3. Global Handheld Ultrasound Devices Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2034 for the following
5.4.1. Obstetrics/Gynecology
5.4.1.1. Obstetrics/Gynecology market estimates and forecasts 2021 to 2034 (USD Million)
5.4.2. Cardiovascular
5.4.2.1. Cardiovascular market estimates and forecasts 2021 to 2034 (USD Million)
5.4.3. Urology
5.4.3.1. Urology market estimates and forecasts 2021 to 2034 (USD Million)
5.4.4. Gastroenterology
5.4.4.1. Gastroenterology market estimates and forecasts 2021 to 2034 (USD Million)
5.4.5. Musculoskeletal
5.4.5.1. Musculoskeletal market estimates and forecasts 2021 to 2034 (USD Million)
5.4.6. Trauma
5.4.6.1. Trauma market estimates and forecasts 2021 to 2034 (USD Million)
5.4.7. Others
5.4.7.1. Others market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 6. Handheld Ultrasound Devices Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2034
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2034:
6.5. North America
6.5.1. Regulatory framework/ reimbursement structure
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework/ Reimbursement structure
6.5.2.4. U.S. market estimates and forecasts 2021 to 2034 (USD Million)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework/ Reimbursement structure
6.5.3.4. Canada market estimates and forecasts 2021 to 2034 (USD Million)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework/ Reimbursement structure
6.5.4.4. Mexico market estimates and forecasts 2021 to 2034 (USD Million)
6.6. Europe
6.6.1. Regulatory framework/ reimbursement structure
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework/ Reimbursement structure Regulatory framework/ Reimbursement structure
6.6.2.4. UK market estimates and forecasts 2021 to 2034 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework/ Reimbursement structure
6.6.3.4. Germany market estimates and forecasts 2021 to 2034 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework/ Reimbursement structure
6.6.4.4. France market estimates and forecasts 2021 to 2034 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework/ Reimbursement structure
6.6.5.4. Italy market estimates and forecasts 2021 to 2034 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework/ Reimbursement structure
6.6.6.4. Spain market estimates and forecasts 2021 to 2034 (USD Million)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework/ Reimbursement structure
6.6.7.4. Norway market estimates and forecasts 2021 to 2034 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework/ Reimbursement structure
6.6.8.4. Sweden market estimates and forecasts 2021 to 2034 (USD Million)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Competitive scenario
6.6.9.3. Regulatory framework/ Reimbursement structure
6.6.9.4. Denmark market estimates and forecasts 2021 to 2034 (USD Million)
6.7. Asia Pacific
6.7.1. Regulatory framework/ reimbursement structure
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework/ Reimbursement structure
6.7.2.4. Japan market estimates and forecasts 2021 to 2034 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework/ Reimbursement structure
6.7.3.4. China market estimates and forecasts 2021 to 2034 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework/ Reimbursement structure
6.7.4.4. India market estimates and forecasts 2021 to 2034 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework/ Reimbursement structure
6.7.5.4. Australia market estimates and forecasts 2021 to 2034 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework/ Reimbursement structure
6.7.6.4. South Korea market estimates and forecasts 2021 to 2034 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework/ Reimbursement structure
6.7.7.4. Thailand market estimates and forecasts 2021 to 2034 (USD Million)
6.8. Latin America
6.8.1. Regulatory framework/ reimbursement structure
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework/ Reimbursement structure
6.8.2.4. Brazil market estimates and forecasts 2021 to 2034 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework/ Reimbursement structure
6.8.3.4. Argentina market estimates and forecasts 2021 to 2034 (USD Million)
6.9. MEA
6.9.1. Regulatory framework/ reimbursement structure
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework/ Reimbursement structure
6.9.2.4. South Africa market estimates and forecasts 2021 to 2034 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework/ Reimbursement structure
6.9.3.4. Saudi Arabia market estimates and forecasts 2021 to 2034 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework/ Reimbursement structure
6.9.4.4. UAE market estimates and forecasts 2021 to 2034 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Competitive scenario
6.9.5.3. Regulatory framework/ Reimbursement structure
6.9.5.4. Kuwait market estimates and forecasts 2021 to 2034 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key customers
7.3.2. Key company market share analysis, 2024
7.3.3. GE HealthCare
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Koninklijke Philips N.V.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. BenQ Medical Technology
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. CHISON Medical Technologies Co., Ltd.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Dawei Medical (Jiangsu) Corp., Ltd.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Viatom Technology Co., Ltd.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Telemed Medical Systems S.r.l.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Butterfly Network, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Pulsenmore Ltd.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Leltek Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
Chapter 8. Analyst Perspective
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers